The Quantum Leap

What could an ordinary day in medicine look like in the year 2040? In the season finale of The Quantum Leap, Dr. Nirdosh Jagota imagines a single day in a future shaped by artificial intelligence, genomic medicine, personalized therapies, advanced diagnostics, automated laboratories, and quantum computing. Every scene is grounded in technology, research, clinical trials, regulatory decisions, or m...

How Big Pharma Is Adopting, Acquiring, and Competing with Deep Tech What does a century-old pharmaceutical company do when the future arrives from a technology company? In this episode of The Quantum Leap, Dr. Nirdosh Jagota examines how the world’s largest pharmaceutical companies are responding to artificial intelligence, advanced computing, biological data platforms, and emerging deep-tech capa...

In this episode of The Quantum Leap, Dr. Nirdosh Jagota steps onto the pharmaceutical factory floor to examine how artificial intelligence, advanced optimization, continuous manufacturing, and digital infrastructure are transforming the way medicines are produced and delivered. Dr. Jagota begins with the urgent challenge of drug shortages and explains why manufacturing reliability is just as impor...

In this episode of The Quantum Leap, Dr. Nirdosh Jagota examines one of the most important challenges facing AI and quantum medicine: how clinicians, regulators, and patients can trust decisions produced by systems whose internal reasoning may be difficult—or impossible—to interpret. Dr. Jagota explains the black box problem and why opacity becomes especially dangerous when algorithms influence di...

In this episode of The Quantum Leap, Dr. Nirdosh Jagota explores how quantum computing could move beyond pharmaceutical research and into hospitals, diagnostics, genomics, and personalized patient care. Building on the previous episode’s discussion of quantum-powered drug design, this installment examines how quantum technologies may help physicians understand complex biological data and make more...

In this episode of The Quantum Leap, Dr. Nirdosh Jagota explores one of the most exciting frontiers in pharmaceutical innovation: quantum simulation. Building on the foundation of quantum computing introduced in the previous episode, he explains how quantum technologies are poised to solve some of the most complex challenges in drug discovery by accurately modeling molecular interactions at the at...

In this milestone episode of The Quantum Leap, Dr. Nirdosh Jagota introduces one of the most transformative technologies on the horizon: quantum computing. As artificial intelligence continues to reshape pharmaceutical research, quantum computing promises to overcome the fundamental limitations of classical computers and unlock entirely new possibilities for medicine. Dr. Jagota explains the origi...

In this episode of The Quantum Leap, Dr. Nirdosh Jagota explores one of the most profound shifts in the history of scientific discovery: the emergence of AI as an active research partner. Moving beyond traditional automation, today's most advanced AI systems are beginning to generate hypotheses, design experiments, analyze results, and even contribute to scientific publications. Dr. Jagota examine...

In this episode of The Quantum Leap, Dr. Nirdosh Jagota steps beyond the science of AI and quantum computing to explore the financial forces driving the future of medicine. As billions of dollars flow into AI-powered biotechnology and quantum-enabled pharmaceutical innovation, understanding the investment landscape has become essential for entrepreneurs, executives, and investors alike. Dr. Jagota...

In this episode of The Quantum Leap, Dr. Nirdosh Jagota explores one of the most exciting frontiers in pharmaceutical innovation: the emergence of the self-driving laboratory. While artificial intelligence has transformed computational drug discovery, the physical process of synthesizing and testing molecules has remained a significant bottleneck. Companies like Exscientia are changing that realit...

In this episode of The Quantum Leap, Dr. Nirdosh Jagota explores a fundamental shift in drug discovery—from traditional target-based approaches to a data-first, phenotypic discovery model powered by artificial intelligence. He examines how companies like Recursion Pharmaceuticals are redefining the scientific method by moving beyond human hypothesis and allowing large-scale biological data to guid...

In this episode of The Quantum Leap, Dr. Nirdosh Jagota shifts the focus from molecules to one of the most critical elements in drug development—the patient. He explores how artificial intelligence is redefining clinical trials through the emergence of AI-powered digital twins, a transformative concept that has the potential to dramatically reduce trial timelines, costs, and uncertainty.  Dr. Jago...

In this episode of The Quantum Leap, Dr. Nirdosh Jagota explores one of the most transformative shifts in modern drug discovery: the emergence of end-to-end AI-driven pharmaceutical pipelines. Moving beyond isolated applications of artificial intelligence, this episode focuses on how companies like Insilico Medicine are integrating AI across the entire value chain—from target identification to cli...

In this episode of The Quantum Leap, Dr. Nirdosh Jagota transitions from foundational scientific discovery to real-world application, examining how breakthroughs like AlphaFold are being translated into commercial drug design platforms. The focus is on Isomorphic Labs, the AI-driven company emerging from Alphabet, which represents a pivotal shift in how therapeutics are conceived, engineered, and...

In this episode of The Quantum Leap, Dr. Nirdosh Jagota examines one of the most consequential scientific breakthroughs of the modern era: the solution to the protein folding problem through DeepMind’s AlphaFold. For more than fifty years, the inability to predict protein structure created a fundamental bottleneck in biological research and drug discovery. AlphaFold’s transformer-based architectur...

In the inaugural episode of The Quantum Leap, Dr. Nirdosh Jagota presents a strategic and forward-looking examination of the AI-native pharmaceutical enterprise—a fundamental departure from the traditional drug development model. Drawing on over three decades of global experience in biotechnology and regulatory leadership, Dr. Jagota analyzes the structural limitations of the current R&D parad...